ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPONSORED PUBLICATIONS

20161130-pressrelease-pharmatio.jpg

Performance in Clinical Trials: Pharmatio GmbH with new Portfolio

Pharmatio GmbH, already established in the monitoring and site liaison of clinical trials, has restructured its services. With Clinical Trial Liaison, the sponsors of clinical trials can ensure the patient … more ➔

DROOMS - Whitepaper

14 Must-Haves to Boost the Efficiency of Your Data Room

Stop wasting time with data room software that doesn’t really improve your workflow. more ➔

ADVERTISEMENT

The Jackson Laboratory

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies. more ➔

RightsDirect

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

How Content Access and Manual Process Hinder Mining Efforts more ➔

placeholder

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 20 of 20«‹181920

LATEST NEWS

Jane Osbourn, Founder and CEO of Alchemab Therapeutics LtdAlchemab Therapeutics Ltd

Alchemab Therapeutics reports US$32m Series A exten...

The Fragile X mutation is a type of genetic mutation called a repeat expansion. This repeat expansion occurs on the FMR1 gene, on the long arm of the X chromosome leading to gene silencing if more than 200 repeats occur.FRAXA Ewsearch Organisation

Servier acquires Kaerus Bioscience’s FXS cand...

Financingadobe stock photos - deemerwha

NRG Therapeutics Ltd bags £50m in Series B financi...

ADVERTISEMENT

MAGAZINE

1 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

2 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

3 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

4 / 4
EB324_Titel

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

SPONSORED PUBLICATION

Messegeschehen / Trade fair activity
POWTECH TECHNOPHARM

About POWTECH TECHNOPHARM

POWTECH TECHNOPHARM (Nuremberg, 23-25 September 2025) is the international trade fair for process engineering experts and a tailor-made technology platform for the pharmaceutical and life science … more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top